+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography- Product Image
Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography- Product Image
Sale

Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography

  • PDF Icon

    Report

  • 179 Pages
  • September 2020
  • Region: Global
  • The Insight Partners
  • ID: 5178573
UP TO OFF until Jun 30th 2024
Description Jump to:
Market for Recombinant Cancer Vaccines to Grow at Fastest CAGR during Forecast Period.

According to this new market research study on “Cancer Vaccines Market to 2027 - Global Analysis and Forecast - by Technology, Type, Indication, and End User,” the market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019; it is estimated to grow at a CAGR of 17.2% from 2020 to 2027. The report highlights trends prevailing in the global cancer vaccines market, and the drivers and restraints pertaining to the market growth.

Based on technology, the cancer vaccines market is segmented into dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, and viral vector cancer vaccines. In 2019, the recombinant cancer vaccines segment accounted for the largest share of the market, and it is further estimated to register the highest CAGR during the forecast period. Growth of the market for this segment is attributed to the escalating demand for effective vaccines and rising prevalence of cancer. In addition, strategic activities by service providers such as collaborations, mergers, acquisitions, and expansions are further accelerating the growth of the market.

The global cancer vaccines market growth is mainly attributed to factors such as increasing incidence of cancer worldwide, and rising number of initiatives taken by healthcare research organizations and key cancer vaccines companies. However, a limited number of commercially available vaccines for treatment of cancer and higher cost of cancer vaccines hinder the market growth.

CSL Limited, ADURO BIOTECH INC., Astellas Pharma Inc., Merck & Co., Inc., Sanofi, Bristol-Myers Squibb Company, Glaxosmithkline Plc., Dendreon, ASTRAZENECA PLC., and OSE Immunotherapeutics are among the leading companies operating in the cancer vaccines market.

The Report Segments Global Cancer Vaccines Market as Follows:

By Technology
  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer Vaccines

By Type
  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccine

By Indication
  • Cervical Cancer
  • Prostate Cancer
  • Other Indications

By End-User
  • Pediatrics
  • Adults

By Geography

North America
  • US
  • Canada
  • Mexico

Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy

Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea

Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer vaccines market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global cancer vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Cancer Vaccines Market - By Technology
1.3.2 Global Cancer Vaccines Market - By Type
1.3.3 Global Cancer Vaccines Market - By Indication
1.3.4 Global Cancer Vaccines Market - By End-User
1.3.5 Global Cancer Vaccines market - By Geography
2. Cancer Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Cancer Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Cancer Vaccines Market- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Prevalence of Cancer Worldwide
5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines
5.2 Key Market Restraints
5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer
5.2.2 Higher Cost of Cancer Vaccines
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact analysis
6. Cancer Vaccines Market - Global Analysis
6.1 Global Cancer Vaccines Market Revenue Forecast and Analysis
6.2 Global Cancer Vaccines Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Cancer Vaccines Market - By Technology
7.1 Overview
7.2 Cancer Vaccines Market, by Technology, 2019 and 2027 (%)
7.3 Dendritic Cells Cancer Vaccine
7.3.1 Overview
7.3.2 Dendritic Cells Cancer Vaccines : Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Recombinant Cancer Vaccines
7.5.1 Overview
7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Antigen Cancer Vaccines
7.6.1 Overview
7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Whole Cell Cancer Vaccines
7.7.1 Overview
7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Viral Vector Cancer Vaccines
7.8.1 Overview
7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8. Cancer Vaccines Market Analysis - By Type
8.1 Overview
8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
8.3 Preventive Cancer Vaccines
8.3.1 Overview
8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Therapeutic Cancer Vaccines
8.4.1 Overview
8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9. Cancer Vaccines Market Analysis - By Indication
9.1 Overview
9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
9.3 Cervical Cancer
9.3.1 Overview
9.3.2 Cervical Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Prostate Cancer
9.4.1 Overview
9.4.2 Prostate Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Other Indications
9.5.1 Overview
9.5.2 Other Indications: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
10. Cancer Vaccines Market Analysis - By End Use
10.1 Overview
10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
10.3 Pediatrics
10.3.1 Overview
10.3.2 Pediatrics: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Adults
10.4.1 Overview
10.4.2 Adults: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
11. Cancer Vaccines Market Analysis And Forecasts To 2027 Geographical Analysis
11.1 North America: Cancer Vaccines Market
11.1.1 Overview
11.1.2 North America: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Cancer Vaccines Market, by Technology, 2018-2027 (USD Million)
11.1.4 North America: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.5 North America: Cancer Vaccines Market, by Indication, 2018-2027 (USD Million)
11.1.6 North America: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.7 North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
11.1.8 US: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.8.3 US: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.8.4 US: Cancer Vaccines Market, by Technology2018-2027 (USD Million)
11.1.8.5 US: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.9 Canada: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.9.3 Canada: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.9.4 Canada: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.9.5 Canada: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.10 Mexico: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.10.3 Mexico: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.10.4 Mexico: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.10.5 Mexico: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.2 Europe: Cancer Vaccines Market
11.2.1 Overview
11.2.2 Europe: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.2.4 Europe: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.2.5 Europe: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.2.6 Europe: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.2.7 Europe: Cancer Vaccines Market, by Country, 2018 & 2027 (%)
11.2.8 Germany: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.2.8.3 Germany: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.2.8.4 Germany: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.2.8.5 Germany: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.2.9 UK: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.1 UK: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.2 UK: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.2.9.3 UK: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.2.9.4 UK: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.2.9.5 UK: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.2.10 France: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.1 France: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.2 France: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.2.10.3 France: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.2.10.4 France: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.2.10.5 France: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.2.11 Spain: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Spain: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Spain: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.2.11.3 Spain: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.2.11.4 Spain: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.2.11.5 Spain: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.2.12 Italy: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Italy: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Italy: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.2.12.3 Italy: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.2.12.4 Italy: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.2.12.5 Italy: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.3 Asia Pacific: Cancer Vaccines Market
11.3.1 Overview
11.3.2 Asia Pacific: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.3.4 Asia Pacific: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.3.5 Asia Pacific: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.3.6 Asia Pacific: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.3.7 Asia Pacific: Cancer Vaccines Market, by Country, 2018 & 2027 (%)
11.3.8 China: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.3.8.3 China: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.3.8.4 China: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.3.8.5 China: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.3.9 Japan: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.3.9.3 Japan: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.3.9.4 Japan: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.3.9.5 Japan: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.3.10 India: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.3.10.3 India: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.3.10.4 India: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.3.10.5 India: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.3.11 South Korea: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.3.11.3 South Korea: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.3.11.4 South Korea: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.3.11.5 South Korea: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.3.12 Australia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Australia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.2 Australia: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.3.12.3 Australia: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.3.12.4 Australia: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.3.12.5 Australia: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.4 Middle East & Africa: Cancer Vaccines Market
11.4.1 Overview
11.4.2 Middle East & Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.4.3 Middle East & Africa: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.4.4 Middle East & Africa: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.4.5 Middle East & Africa: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.4.6 Middle East & Africa: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.4.7 Middle East & Africa: Cancer Vaccines Market Share by Country - 2019 & 2027, (%)
11.4.8 Saudi Arabia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.4.8.3 Saudi Arabia: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.4.8.4 Saudi Arabia: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.4.8.5 Saudi Arabia: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.4.9 UAE: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.4.9.3 UAE: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.4.9.4 UAE: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.4.9.5 UAE: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.4.10 South Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
11.4.10.1 South Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.4.10.3 South Africa: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.4.10.4 South Africa: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.4.10.5 South Africa: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.5 South and Central America: Cancer Vaccines Market
11.5.1 Overview
11.5.2 South and Central America: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.5.3 South and Central America Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.5.4 South and Central America Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
11.5.5 South and Central America Cancer Vaccines Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.5.6 South and Central America Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.5.7 South and Central America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
11.5.8 Brazil: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.5.8.3 Brazil Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
11.5.8.4 Brazil Cancer Vaccines Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.5.8.5 Brazil Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.5.9 Argentina: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.5.9.3 Argentina Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
11.5.9.4 Argentina Cancer Vaccines Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.5.9.5 Argentina Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of World: Impact Assessment of COVID-19 Pandemic
13. Cancer Vaccines Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 CSL Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ADURO BIOTECH INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bristol-Myers Squibb Company
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Dendreon
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Merck & Co., Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sanofi (Sanofi Pasteur)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 OSE Immunotherapeutics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • CSL Limited
  • ADURO BIOTECH INC.
  • Astellas Pharma Inc.
  • Merck & Co. Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Glaxosmithkline Plc.
  • Dendreon
  • ASTRAZENECA PLC.
  • OSE Immunotherapeutics

Related Topics

Related Reports

Global Cancer Vaccine Market ,Vaccine Price, Dosage, Sales & Clinical Trials Outlook 2029 - Product Image

Global Cancer Vaccine Market ,Vaccine Price, Dosage, Sales & Clinical Trials Outlook 2029

  • Report
  • 840 Pages
  • Global
From
US cancer vaccine industry outlook to 2028 - Product Image

US cancer vaccine industry outlook to 2028

  • Report
  • 85 Pages
  • United States
From
Global Cancer Vaccines Market by Technology (Antigen, Dendritic Cells, Recombinant Cancer Vaccines), Treatment Method (Preventive Vaccine, Therapeutic Vaccine), Application - Forecast 2024-2030 - Product Image

Global Cancer Vaccines Market by Technology (Antigen, Dendritic Cells, Recombinant Cancer Vaccines), Treatment Method (Preventive Vaccine, Therapeutic Vaccine), Application - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Cancer Vaccine Market Size, Share & Trends Analysis Report By Indication Type (Bladder, Cervical), By Vaccine Type (Preventive, Therapeutic), By Technology Type (Recombinant, Whole-cell), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cancer Vaccine Market Size, Share & Trends Analysis Report By Indication Type (Bladder, Cervical), By Vaccine Type (Preventive, Therapeutic), By Technology Type (Recombinant, Whole-cell), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 130 Pages
  • Global
From
Global Human Papillomavirus Vaccine Market by Disease Indication (Anal Cancer, Cervical Cancer, Genital Warts), Type (Bivalent, Tetravalent & Nonavalent), Distribution Channel - Forecast 2024-2030 - Product Image

Global Human Papillomavirus Vaccine Market by Disease Indication (Anal Cancer, Cervical Cancer, Genital Warts), Type (Bivalent, Tetravalent & Nonavalent), Distribution Channel - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.